First Trust Advisors LP Mannkind Corp Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$3.25 - $5.27 $1.85 Million - $3 Million
-568,369 Reduced 84.9%
101,124 $458,000
Q4 2023

Feb 13, 2024
BUY
$3.34 - $4.29 $1.52 Million - $1.96 Million
456,065 Added 213.69%
669,493 $2.44 Million
Q3 2023

Nov 13, 2023
SELL
$3.91 - $5.45 $219,006 - $305,265
-56,012 Reduced 20.79%
213,428 $881,000
Q2 2023

Aug 14, 2023
BUY
$3.72 - $4.79 $1 Million - $1.29 Million
269,440 New
269,440 $1.1 Million

Others Institutions Holding MNKD

# of Institutions
245
Shares Held
148M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email